Dr Wajid Hussain appointed new clinical director for digital health at RCP

pharmafile | August 2, 2019 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IT, RCP, Royal College of Physicians, digital health, pharma 

The Royal College of Physicians (RCP) has appointed Dr Wajid Hussain as its new clinical director for digital health.

Dr Hussain, a cardiologist and cardiac electrophysicist at the Royal Brompton and Harefield NHS Trust, has a demonstrated interest in IT and health.

While he currently represents the views of clinicians on the Trust’s IT committee, Dr Hussain completed a Diploma in Digital Health Leadership at the NHS Digital Academy last year. He is also currently studying for a Master’s in Digital Health leadership at Imperial College London.

Commenting on his own appointment, Dr Hussain said: “I have always wanted to help facilitate change and have become increasingly focussed on digital healthcare as a way of effecting that change. The role of RCP clinical director for digital health will enable me to do this on a national and international scale.”

“This is a unique role within a unique organisation, which has the ability to influence the whole healthcare system.  I am hoping to be a bridge between clinicians and IT within and outside the organisation.  I look forward to working closely with colleagues and stakeholders to further embed and develop this important work.”

Professor David Oliver, RCP clinical vice president, added: “I am pleased to welcome Dr Wajid Hussain to the RCP. Wajid brings with him a wealth of experience from across the NHS in leading programmes to improve care for patients, together with his impressive track record of technological innovation to clinical practice. His expertise in digital health is sure to be a huge asset for the RCP’s work on matters relating to digital health.”

Related Content

NHS-integrated pharmacy app Charac receives £1.2m funding

Charac, an NHS-integrated pharmacy app, has raised £1.2m in debt and equity financing from the …

FDA approves IMIDEX’s AI-powered device VisiRad XR

The technological pharmaceutical company IMIDEX has been granted clearance from the US Food and Drug …

Artiva Biotherapeutics announces FDA clearance of IND for AlloNK and Rituximab combo

On 16 August 2023, the US Food and Drug Administration (FDA) officially cleared Artiva Biotherapeutics’ …

Latest content